SEATTLE, April 16, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, announced today that, due to… Read More
March 30, 2020 bioLytical Laboratories Inc., a world leader in rapid diagnostic tests for infectious diseases, is pleased to announce that its CEO, Livleen Veslemes, was recognized as the Change… Read More
Products made by Vancouver’s STEMCELL Technologies are now being used in over 30 COVID-19 studies worldwide. These studies are focusing on areas ranging from diagnostics and treatments to vaccine development and future… Read More
New Danaher operating company created following completion of $21.4B acquisition by Danaher Corporation Previously GE Healthcare Life Sciences, Cytiva will help accelerate growth and innovation in biological therapies Leading life… Read More
MSFHR SHIFTS COMPETITION DEADLINES TO SUPPORT APPLICANTS INVOLVED IN COVID-19 EMERGENCY RESPONSE April 06, 2020 The MSFHR COVID-19 Research Response Fund opens today (April 6) with the first of several funding calls… Read More
